ArticleJournal of cancer research and clinical oncology2023

Efficacy and safety of EGFR‑TKIs plus Shenqi Fuzheng injection for non-small cell lung cancer patients with EGFR-sensitive mutations.

Jia-Li Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.